Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid pharmacokinetics study of ECM-E
jRCT1091220141Completed
- Sponsor
- Adaptgen Pharmaceutical
- Start
- Sep 2013
- Countries
- 1
01
Overview
Randomised, double-blind trial of ECM-E (3 arms), sponsored by Adaptgen Pharmaceutical. Primary endpoint: Blood kinetics of hyaluronic acid. Started Sep 2013; status: completed.
02
Drugs
ECM-E
Beyond the preview
Go deeper on jRCT1091220141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220141.